Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies

References

• Patel KP, Vunnam SR, Patel PA, Krill KL, Korbitz PM, Gallagher JP, Suh JE, Vunnam RR. Transmission of SARS-CoV-2: an update of current literature. Eur J Clin Microbiol Infect Dis. 2020;39(11):2005–2011.
   PubMed Web of Science ®Google Scholar
• Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, Wang YY, Xiao GF, Yan B, Shi ZL, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386–389.
   PubMed Web of Science ®Google Scholar
• Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39(5):405–407.
   PubMed Web of Science ®Google Scholar
• Yang H, Rao Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat Rev Microbiol. 2021;19(11):685–700.
   PubMed Web of Science ®Google Scholar
• Fehr AR, Perlman SJC. Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses. 2015;1282:1–23.
   Google Scholar
• Abd-Alla HI, Kutkat O, Sweelam H-tM, Eldehna WM, Mostafa MA, Ibrahim MT, Moatasim Y, GabAllah M, Al-Karmalawy AA. Investigating the potential anti-SARS-CoV-2 and anti-MERS-CoV activities of yellow necklacepod among three selected medicinal plants: extraction, isolation, identification, in vitro, modes of action, and molecular docking studies. Metabolites. 2022;12(11):1109.
   PubMed Web of Science ®Google Scholar
• Menendez JC. Approaches to the potential therapy of COVID-19: a general overview from the medicinal chemistry perspective. Molecules. 2022;27(3):658.
   PubMed Web of Science ®Google Scholar
• Elmaaty AA, Eldehna WM, Khattab M, Kutkat O, Alnajjar R, El-Taweel AN, Al-Rashood ST, Abourehab MAS, Binjubair FA, Saleh MA, et al. Anticoagulants as potential SARS-CoV-2 Mpro inhibitors for COVID-19 patients: in vitro, molecular docking, molecular dynamics, DFT, and SAR studies. Int J Mol Sci. 2022;23(20):12235.
   PubMed Web of Science ®Google Scholar
• Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY. Coronaviruses – drug discovery and therapeutic options. Nat Rev Drug Discov. 2016;15(5):327–347.
   PubMed Web of Science ®Google Scholar
• Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, Boras B, Cardin RD, Carlo A, Coffman KJ, et al. An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19. Science. 2021;374(6575):1586–1593.
   PubMed Web of Science ®Google Scholar
• Akinosoglou K, Schinas G, Gogos C. Oral antiviral treatment for COVID-19: a comprehensive review on nirmatrelvir/ritonavir. Viruses. 2022;14(11):2540.
   PubMed Web of Science ®Google Scholar
• Hoffman RL, Kania RS, Brothers MA, Davies JF, Ferre RA, Gajiwala KS, He M, Hogan RJ, Kozminski K, Li LY, et al. Discovery of ketone-based covalent inhibitors of coronavirus 3CL proteases for the potential therapeutic treatment of COVID-19. J Med Chem. 2020;63(21):12725–12747.
   PubMed Web of Science ®Google Scholar
• Cooper CL, van Heeswijk RP, Gallicano K, Cameron DW. A review of low-dose ritonavir in protease inhibitor combination therapy. Clin Infect Dis. 2003;36(12):1585–1592.
   PubMed Web of Science ®Google Scholar
• Ashour NA, Elmaaty AA, Sarhan AA, Elkaeed EB, Moussa AM, Erfan IA, Al-Karmalawy AA. A systematic review of the global intervention for SARS-CoV-2 combating: from drugs repurposing to molnupiravir approval. Drug Des Devel Ther. 2022;16:685–715.
   PubMed Web of Science ®Google Scholar
• Yan F, Gao F. An overview of potential inhibitors targeting non-structural proteins 3 (PL(pro) and Mac1) and 5 (3CL(pro)/M(pro)) of SARS-CoV-2. Comput Struct Biotechnol J. 2021;19:4868–4883.
   PubMed Web of Science ®Google Scholar
• Jain R, Mujwar S. Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19. Struct Chem. 2020;31(6):2487–2499.
   PubMed Web of Science ®Google Scholar
• Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y, Xie X, Jin Z, Peng J, Liu F, et al. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science. 2020;368(6497):1331–1335.
   PubMed Web of Science ®Google Scholar
• Aljuhani A, Ahmed HEA, Ihmaid SK, Omar AM, Althagfan SS, Alahmadi YM, Ahmad I, Patel H, Ahmed S, Almikhlafi MA, et al. In vitro and computational investigations of novel synthetic carboxamide-linked pyridopyrrolopyrimidines with potent activity as SARS-CoV-2-MPro inhibitors. RSC Adv. 2022;12(41):26895–26907.
   PubMed Web of Science ®Google Scholar
• El-Masry RM, Al-Karmalawy AA, Alnajjar R, Mahmoud SH, Mostafa A, Kadry HH, Abou-Seri SM, Taher AT. Newly synthesized series of oxoindole–oxadiazole conjugates as potential anti-SARS-CoV-2 agents: in silico and in vitro studies. New J Chem. 2022;46(11):5078–5090.
   Web of Science ®Google Scholar
• Mengist HM, Dilnessa T, Jin T. Structural basis of potential inhibitors targeting SARS-CoV-2 main protease. Front Chem. 2021;9:622898.
   PubMed Web of Science ®Google Scholar
• Sabbah DA, Hajjo R, Bardaweel SK, Zhong HA. An updated review on SARS-CoV-2 main proteinase (M(Pro)): protein structure and small-molecule inhibitors. Curr Top Med Chem. 2021;21(6):442–460.
   PubMed Web of Science ®Google Scholar
• Zhu G, Zhu C, Zhu Y, Sun F. Minireview of progress in the structural study of SARS-CoV-2 proteins. Curr Res Microb Sci. 2020;1:53–61.
   PubMedGoogle Scholar
• Zheng L, Zhang L, Huang J, Nandakumar KS, Liu S, Cheng K. Potential treatment methods targeting 2019-nCoV infection. Eur J Med Chem. 2020;205:112687.
   PubMed Web of Science ®Google Scholar
• Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science. 2020;368(6489):409–412.
   PubMed Web of Science ®Google Scholar
• Shie JJ, Fang JM, Kuo CJ, Kuo TH, Liang PH, Huang HJ, Yang WB, Lin CH, Chen JL, Wu YT, et al. Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease. J Med Chem. 2005;48(13):4469–4473.
   PubMed Web of Science ®Google Scholar
• Gilbert NC, Gerstmeier J, Schexnaydre EE, Börner F, Garscha U, Neau DB, Werz O, Newcomer ME. Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products. Nat Chem Biol. 2020;16(7):783–790.
   PubMed Web of Science ®Google Scholar
• Orhan IE, Senol Deniz FS. Natural products as potential leads against coronaviruses: could they be encouraging structural models against SARS-CoV-2? Nat Prod Bioprospect. 2020;10(4):171–186.
   PubMed Web of Science ®Google Scholar
• Razali R, Asis H, Budiman C. Structure–function characteristics of SARS-CoV-2 proteases and their potential inhibitors from microbial sources. Microorganisms. 2021;9(12):2481.
   PubMed Web of Science ®Google Scholar
• Turk B. Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov. 2006;5(9):785–799.
   PubMed Web of Science ®Google Scholar
• Drag M, Salvesen GS. Emerging principles in protease-based drug discovery. Nat Rev Drug Discov. 2010;9(9):690–701.
   PubMed Web of Science ®Google Scholar
• Elagawany M, Elmaaty AA, Mostafa A, Abo Shama NM, Santali EY, Elgendy B, Al-Karmalawy AA. Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease. J Enzyme Inhib Med Chem. 2022;37(1):2112–2132.
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. Liposomes in drug delivery: how it all happened. Pharmaceutics. 2016;8(2):19.
   PubMed Web of Science ®Google Scholar
• Aldawsari HM, Ahmed OA, Alhakamy NA, Neamatallah T, Fahmy UA, Badr-Eldin SM. Lipidic nano-sized emulsomes potentiates the cytotoxic and apoptotic effects of raloxifene hydrochloride in MCF-7 human breast cancer cells: factorial analysis and in vitro anti-tumor activity assessment. Pharmaceutics. 2021;13(6):783.
   PubMed Web of Science ®Google Scholar
• Hegazy H, Amin MM, Fayad W, Zakaria MY. TPGS surface modified bilosomes as boosting cytotoxic oral delivery systems of curcumin against doxorubicin resistant MCF-7 breast cancer cells. Int J Pharm. 2022;619:121717.
   PubMedGoogle Scholar
• Dubey S, Vyas S. Emulsomes for lipophilic anticancer drug delivery: development, optimization and in vitro drug release kinetic study. Int J App Pharm. 2021;13:114–121.
   PubMedGoogle Scholar
• Zakaria MY, Georghiou PE, Banoub JH, Beshay BY. Inclusion of a phytomedicinal flavonoid in biocompatible surface-modified chylomicron mimic nanovesicles with improved oral bioavailability and virucidal activity: molecular modeling and pharmacodynamic studies. Pharmaceutics. 2022;14(5):905.
   PubMed Web of Science ®Google Scholar
• Abdelbary GA, Amin MM, Zakaria MY. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies. Drug Deliv. 2017;24(1):309–319.
   PubMed Web of Science ®Google Scholar
• Abd El-Halim SM, Abdelbary GA, Amin MM, Zakaria MY, Shamsel-Din HA, Ibrahim AB. Stabilized oral nanostructured lipid carriers of adefovir dipivoxil as a potential liver targeting: estimation of liver function panel and uptake following intravenous injection of radioiodinated indicator. Daru. 2020;28(2):517–532.
   PubMed Web of Science ®Google Scholar
• Anwer KE, El-Sattar NEA, Shamaa MM, Zakaria MY, Beshay BY. Design, green synthesis and tailoring of vitamin E TPGS augmented niosomal nano-carrier of pyrazolopyrimidines as potential anti-liver and breast cancer agents with accentuated oral bioavailability. Pharmaceuticals. 2022;15(3):330.
   Web of Science ®Google Scholar
• Mahmoud DB, Bakr MM, Al-Karmalawy AA, Moatasim Y, El Taweel A, Mostafa A. Scrutinizing the feasibility of nonionic surfactants to form isotropic bicelles of curcumin: a potential antiviral candidate against COVID-19. AAPS PharmSciTech. 2022;23(1):1–12.
   Web of Science ®Google Scholar
• Marques NP, Lopes CS, Marques NCT, Cosme-Silva L, Oliveira TM, Duque C, Sakai VT, Hanemann JAC. A preliminary comparison between the effects of red and infrared laser irradiation on viability and proliferation of SHED. Lasers Med Sci. 2019;34(3):465–471.
   PubMed Web of Science ®Google Scholar
• Chemical Computing Group Inc. Molecular operating environment (MOE). Montreal (Canada): Chemical Computing Group Inc.; 2016. p. 1010.
   Google Scholar
• Al-Karmalawy AA, Farid MM, Mostafa A, Ragheb AY, Mahmoud SH, Shehata M, Shama NMA, GabAllah M, Mostafa-Hedeab G, Marzouk MM. Naturally available flavonoid aglycones as potential antiviral drug candidates against SARS-CoV-2. Molecules. 2021;26(21):6559.
   PubMed Web of Science ®Google Scholar
• Khattab M, Al-Karmalawy AA. Computational repurposing of benzimidazole anthelmintic drugs as potential colchicine binding site inhibitors. Future Med Chem. 2021;13(19):1623–1638.
   PubMed Web of Science ®Google Scholar
• Elebeedy D, Badawy I, Elmaaty AA, Saleh MM, Kandeil A, Ghanem A, Kutkat O, Alnajjar R, Abd El Maksoud AI, Al-Karmalawy AA. In vitro and computational insights revealing the potential inhibitory effect of tanshinone IIA against influenza A virus. Comput Biol Med. 2022;141:105149.
   PubMed Web of Science ®Google Scholar
• Elmaaty AA, Darwish KM, Chrouda A, Boseila AA, Tantawy MA, Elhady SS, Shaik AB, Mustafa M, Al-Karmalawy AA. In silico and in vitro studies for benzimidazole anthelmintics repurposing as VEGFR-2 antagonists: novel mebendazole-loaded mixed micelles with enhanced dissolution and anticancer activity. ACS Omega. 2022;7(1):875–899.
   PubMed Web of Science ®Google Scholar
• Schrödinger Release. 3: Desmond molecular dynamics system, DE Shaw research, New York, NY, 2017. New York (NY): Maestro-Desmond Interoperability Tools, Schrödinger; 2017.
   Google Scholar
• Maestro-Desmond Interoperability Tools. New York (NY): Schrödinger; 2017.
   Google Scholar
• Farouk F, Elmaaty AA, Elkamhawy A, Tawfik HO, Alnajjar R, Abourehab MAS, Saleh MA, Eldehna WM, Al‐Karmalawy AA. Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies. J Enzyme Inhib Med Chem. 2023;38(1):2171029.
   PubMed Web of Science ®Google Scholar
• Zakaria MY, Zaki I, Alhomrani M, Alamri AS, Abdulaziz O, Abourehab MA. Boosting the anti MERS-CoV activity and oral bioavailability of resveratrol via PEG-stabilized emulsomal nano-carrier: factorial design, in-vitro and in-vivo assessments. Drug Deliv. 2022;29(1):3155–3167.
   PubMed Web of Science ®Google Scholar
• Albash R, Yousry C, Al-Mahallawi AM, Alaa-Eldin AA. Utilization of PEGylated cerosomes for effective topical delivery of fenticonazole nitrate: in-vitro characterization, statistical optimization, and in-vivo assessment. Drug Deliv. 2021;28(1):1–9.
   PubMed Web of Science ®Google Scholar
• El Zaafarany GM, Awad GA, Holayel SM, Mortada ND. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 2010;397(1–2):164–172.
   PubMed Web of Science ®Google Scholar
• Stetefeld J, McKenna SA, Patel TR. Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophys Rev. 2016;8(4):409–427.
   PubMedGoogle Scholar
• Zeb A, Qureshi OS, Kim H-S, Cha J-H, Kim H-S, Kim J-K. Improved skin permeation of methotrexate via nanosized ultradeformable liposomes. Int J Nanomedicine. 2016;11:3813–3824.
   PubMed Web of Science ®Google Scholar
• Deng P, Felemban A, Masoud RE, Alamoudi WM, Zakaria MY. Employment of PEGylated ultra-deformable transferosomes for transdermal delivery of tapentadol with boosted bioavailability and analgesic activity in post-surgical pain. Int J Pharm. 2022;628:122274.
   PubMedGoogle Scholar
• Zakaria MY, Abd El-Halim SM, Beshay BY, Zaki I, Abourehab MA. ‘Poly phenolic phytoceutical loaded nano-bilosomes for enhanced caco-2 cell permeability and SARS-CoV 2 antiviral activity’: in-vitro and in-silico studies. Drug Deliv. 2023;30(1):2162157.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Xiong J, Feng S-S. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm. 2011;421(2):332–340.
   PubMed Web of Science ®Google Scholar
• Zakaria MY, Fayad E, Althobaiti F, Zaki I, Abu Almaaty AH. Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: accentuated antiviral and anti-inflammatory activity in MERS-CoV challenged mice. Drug Deliv. 2021;28(1):1150–1165.
   PubMed Web of Science ®Google Scholar
• Alemi A, Zavar Reza J, Haghiralsadat F, Zarei Jaliani H, Haghi Karamallah M, Hosseini SA, Haghi Karamallah S. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy. J Nanobiotechnol. 2018;16(1):1–20.
   PubMedGoogle Scholar
• Elkamhawy A, Son S, Lee HY, El-Maghrabey MH, Hamd MAE, Alshammari SO, Abdelhameed AA, Alshammari QA, Abdeen A, Ibrahim SF, et al. Design, synthesis, biological evaluation, and molecular dynamics studies of novel lapatinib derivatives. Pharmaceuticals. 2022;16(1):43.
   Web of Science ®Google Scholar
• Tang K, Wang S, Gao W, Song Y, Yu B. Harnessing the cyclization strategy for new drug discovery. Acta Pharm Sin B. 2022;12(12):4309–4326.
   PubMed Web of Science ®Google Scholar